It is likely thatsimilar patterns may be being observed here, with hypoglycaemia already known to bea major driver of hospital readmission30 and mortality.31 It is possible that T2DM patients, who are on insulin or gliclazide, and T1DM(who are all on insulin) are the drivers of the results observed here, for both thegeneralised population of patients with diabetes and T1DM cohort. The gene discussed is INS; the disease is type 1 diabetes mellitus.